טוען...
A narrative review of current trends in liraglutide: insights into the unmet needs in management of type 2 diabetes and obesity
Liraglutide is a long-acting human glucagon-like peptide-1 (GLP-1) analogue and an effective treatment for patients with metabolic diseases including type 2 diabetes mellitus (T2DM) and obesity. This review focuses on the mechanism of action of liraglutide as a well-known glucagon-like peptide-1 rec...
שמור ב:
| הוצא לאור ב: | J Diabetes Metab Disord |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7843728/ https://ncbi.nlm.nih.gov/pubmed/33520865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40200-020-00619-9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|